176 related articles for article (PubMed ID: 26114809)
1. Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii.
Vila-Farrés X; López-Rojas R; Pachón-Ibáñez ME; Teixidó M; Pachón J; Vila J; Giralt E
Eur J Med Chem; 2015 Aug; 101():34-40. PubMed ID: 26114809
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR
Hassan A; Ikram A; Raza A; Saeed S; Zafar Paracha R; Younas Z; Khadim MT
Int J Nanomedicine; 2021; 16():3755-3773. PubMed ID: 34103914
[TBL] [Abstract][Full Text] [Related]
4. Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.
Irazazabal LN; Porto WF; Ribeiro SM; Casale S; Humblot V; Ladram A; Franco OL
Biochim Biophys Acta; 2016 Nov; 1858(11):2699-2708. PubMed ID: 27423268
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
7. The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14.
Howl J; Howl L; Jones S
Peptides; 2018 Mar; 101():95-105. PubMed ID: 29337270
[TBL] [Abstract][Full Text] [Related]
8. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
9. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
[TBL] [Abstract][Full Text] [Related]
10. An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.
Oddo A; Thomsen TT; Kjelstrup S; Gorey C; Franzyk H; Frimodt-Møller N; Løbner-Olesen A; Hansen PR
Antimicrob Agents Chemother; 2016 Jan; 60(1):592-9. PubMed ID: 26574005
[TBL] [Abstract][Full Text] [Related]
11. Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants with Extended Antibacterial Properties.
Oshiro KGN; Cândido ES; Chan LY; Torres MDT; Monges BED; Rodrigues SG; Porto WF; Ribeiro SM; Henriques ST; Lu TK; de la Fuente-Nunez C; Craik DJ; Franco OL; Cardoso MH
J Med Chem; 2019 Sep; 62(17):8140-8151. PubMed ID: 31411881
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of synthetic all-D mastoparan M.
Li ML; Liao RW; Qiu JW; Wang ZJ; Wu TM
Int J Antimicrob Agents; 2000 Jan; 13(3):203-8. PubMed ID: 10724025
[TBL] [Abstract][Full Text] [Related]
13. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii.
Christoff RM; Murray GL; Kostoulias XP; Peleg AY; Abbott BM
Bioorg Med Chem; 2017 Dec; 25(24):6267-6272. PubMed ID: 29032931
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant
das Neves RC; Mortari MR; Schwartz EF; Kipnis A; Junqueira-Kipnis AP
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30974767
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.
Kempf M; Djouhri-Bouktab L; Brunel JM; Raoult D; Rolain JM
Int J Antimicrob Agents; 2012 Feb; 39(2):180-1. PubMed ID: 22100281
[No Abstract] [Full Text] [Related]
18. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
20. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
